mivazerol has been researched along with Coronary Disease in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
De Lange, S; Prinzen, FW; Roekaerts, PM; Willigers, HM | 1 |
Goldman, L; Holme, I; Julian, DG; Oliver, MF | 1 |
1 trial(s) available for mivazerol and Coronary Disease
Article | Year |
---|---|
Effect of mivazerol on perioperative cardiac complications during non-cardiac surgery in patients with coronary heart disease: the European Mivazerol Trial (EMIT).
Topics: Adrenergic alpha-Agonists; Aged; Anesthesia, General; Coronary Disease; Double-Blind Method; Female; Humans; Imidazoles; Intraoperative Complications; Male; Placebos; Postoperative Complications; Risk Factors; Surgical Procedures, Operative; Sympatholytics; Vascular Surgical Procedures | 1999 |
1 other study(ies) available for mivazerol and Coronary Disease
Article | Year |
---|---|
The effects of alpha 2-adrenergic stimulation with mivazerol on myocardial blood flow and function during coronary artery stenosis in anesthetized dogs.
Topics: Adrenergic alpha-Agonists; Animals; Cardiac Output; Catecholamines; Coronary Circulation; Coronary Disease; Dogs; Hemodynamics; Imidazoles; Myocardial Contraction; Myocardium; Oxygen Consumption; Regional Blood Flow; Vascular Resistance | 1996 |